A shift in Middle East geopolitical risk has lowered energy costs and gilt yields, while a rare joint US-Japan intervention aims to stabilize the yen.

A potential merger between AstraZeneca and Bristol Myers Squibb would create one of the world's largest pharmaceutical groups, though regulators may oppose the deal due to competing cancer immunotherapies.